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ABSTRACT
The adenovirus E4 open-reading-frame 4 (E4orf4)
protein regulates the progression of viral infection
and when expressed individually it induces
non-classical apoptosis in transformed cells. Here
we show that E4orf4 associates with the ATP-
dependent chromatin-remodeling factor ACF that
consists of a sucrose non fermenting-2h (SNF2h)
ATPase and an Acf1 regulatory subunit. Further-
more, E4orf4 targets protein phosphatase 2A
(PP2A) to this complex and to chromatin.
Obstruction of SNF2h activity inhibits E4orf4-
induced cell death, whereas knockdown of Acf1
results in enhanced E4orf4-induced toxicity in both
mammalian and yeast cells, and Acf1 overexpres-
sion inhibits E4orf40s ability to downregulate early
adenovirus gene expression in the context of viral
infection. Knockdown of the Acf1 homolog, WSTF,
inhibits E4orf4-induced cell death. Based on these
results we suggest that the E4orf4–PP2A complex
inhibits ACF and facilitates enhanced chromatin-
remodeling activities of other SNF2h-containing
complexes, such as WSTF–SNF2h. The resulting
switch in chromatin remodeling determines life
versus death decisions and contributes to E4orf4
functions during adenovirus infection.
INTRODUCTION
The adenovirus E4 open reading frame 4 protein (E4orf4)
is a multifunctional viral regulator. Within the context
of the virus, E4orf4 contributes to temporal regulation
of the progression of viral infection by downregulating
early viral gene expression (1–4), inducing
hypophosphorylation of various viral and cellular
proteins (4,5), facilitating alternative splicing of adeno-
virus mRNAs (5), and regulating protein translation
through an interaction with the mammalian target of
rapamycin (mTOR) pathway (6). E4orf4 has also been
shown to affect virus DNA replication, although this
may be an indirect effect (7,8). When expressed individu-
ally in many cell lines, E4orf4 induces caspase-
independent, non-classical apoptosis (9–12) that is
preceded by G2/M arrest (13–15). At least part of the
E4orf4 signaling network is highly conserved in evolution
from yeast to mammalian cells (14,16–18), underscoring
its importance to cell regulation. Notably, E4orf4-induced
non-classical apoptosis is more efﬁcient in oncogene-
transformed cells (19), suggesting that elucidation of
E4orf4 signaling may open up new cancer therapy
strategies.
Studies of the mechanisms underlying E4orf4 action
identiﬁed several E4orf4 partners. This group of proteins
includes the B55/Ba and B56 subunits of protein phosphat-
ase 2A (PP2A) (2,20), Src family kinases (21,22), the
anaphase-promoting complex/cyclosome in the budding
yeast (14), a subset of serine–arginine (SR)-rich splicing
factors proteins (23) and Ynd1/Golgi UDPase (17).
PP2A is a major E4orf4 partner, and its interaction with
E4orf4 was shown to contribute to all currently known
functions of the viral protein (2,6,19,23–25). PP2A is
composed usually of three subunits: the catalytic C
subunit, a scaffolding A subunit and one of several
regulatory B subunits encoded by at least four unrelated
gene families: PR55/B55/B, PR61/B56/B0,B 00, and B000
[reviewed in (26)]. The various regulatory B subunits
were proposed to dictate substrate speciﬁcity of the
PP2A holoenzyme. Diverse PP2A complexes containing
different B subunits may contribute to the various
E4orf4 functions. Thus, for example, interaction with the
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contributes to E4orf4-induced cell death and cell cycle
arrest in both yeast and mammalian cells (14,18,20).
To enable gene transcription, DNA replication, DNA
repair and DNA recombination in the eukaryotic cell,
numerous protein factors must obtain access to the gen-
ome that is tightly packed in chromatin. To facilitate
accessibility of such factors to regulatory sequences in
the DNA, cells utilize histone-modifying enzymes and
ATP-dependent chromatin-remodeling complexes. ATP-
dependentchromatin-remodeling complexes usetheenergy
produced by ATP hydrolysis to disrupt contacts between
DNA and histones thus facilitating repositioning or re-
moval of nucleosomes or allowing exchange of histone
variants without nucleosomal removal (27). There are cur-
rently four known families of chromatin-remodeling
ATPases, including SWItch/Sucrose non fermentable
(SWI/SNF), imitation switch/sucrose non fermenting
(ISWI), chromo-helicase/ATPase DNA binding (CHD)
and INO80. These proteins possess a similar ATPase
domain but contain additional unique domains and asso-
ciate with different regulatory subunits (28). Mammalian
cells have two ISWI homologs, SNF2h and SNF2l that
display tissue-speciﬁc expression patterns (29). SNF2h
appears in at least seven different complexes, including
human ATP-utilizing chromatin assembly and remodeling
factor/Williams syndrome transcription factor-related
chromatin remodeling factor (hACF/WCRF), chromatin-
accessibility complex (CHRAC), WSTF–ISWI chromatin-
remodeling complex (WICH), B-WICH, remodeling and
spacing factor (RSF), nucleolar remodeling complex
(NoRC) and a large complex containing cohesin and
subunits of the nucleosome remodeling and deacetylase
(NuRD) complex [reviewed in (30)]. In addition, ISWIs
interact functionally with many important cell regulators
participating in a variety of biological processes (31). The
ATP-utilizing chromatin assembly and modifying factor
(ACF) complex contains the SNF2h ATPase and the
Acf1/Baz1A regulatory subunit, and participates in the
regulation of DNA replication and in downregulation of
transcription of speciﬁc genes (32–37). Acf1 and SNF2h
also contribute to DNA damage repair (38). An Acf1
homolog, WSTF/Baz1B (Williams–Beurens syndrome tran-
scription factor) participates in at least two chromatin-
remodeling complexes, and one of them, WICH, contains
the SNF2h catalytic subunit (39,40) and participates in rep-
lication of heterochromatin and in the cellular response to
DNA damage (39,41,42).
In this study, we have examined the physical and func-
tional interactions between E4orf4 and the ACF chromatin-
remodeling factor. We show that E4orf4 targets PP2A to a
complex with Acf1. Obstruction of SNF2h activity inhibits
E4orf4-induced cell death, whereas Acf1 knockdown enha-
nces it. In contrast, knockdown of another SNF2h regula-
tory subunit, WSTF, a component of the WICH complex,
inhibits E4orf4 activity. Acf1 overexpression prevents down-
regulation of an early adenovirus protein by E4orf4 during
viral infection. Our results suggest that E4orf4 inhibits
Acf1-containing chromatin-remodeling complexes and
shifts the balance of chromatin remodeling from Acf1-
SNF2h to other SNF2h-containing complexes, such as
WSTF–SNF2h. This shift is likely to cause alterations in
chromatin that result in the induction of cell death by
E4orf4 and contribute to E4orf4 functions during virus
infection.
MATERIALS METHODS
Cell lines, transfections, plasmids, and yeast strains
HEK293 and HEK293T cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with
10% fetal calf serum (FCS). HEK293-derived cell lines
containing tetracycline-inducible E4orf4 (clone 13) or an
empty vector (T-REX) (24) were propagated in DMEM
supplemented with 10% FCS guaranteed to be tetracyc-
line free (BD Bioscience), 5mg/ml blasticidine (Invitrogen)
and 200mg/ml zeocin (Invitrogen). Cell lines expressing
short hairpin RNAs (shRNAs) or containing an
empty vector were derived from HEK293-T-Rex cells
(Invitrogen) by transfection of speciﬁc shRNAs cloned
into pSuperior.neo-GFP (OligoEngine, Inc.), followed by
a 2-week selection in medium containing 500mg/ml G418
and 5mg/ml blasticidine (Invitrogen).
The following plasmids have been used in this work:
pEGFP-C1 (BD Bioscience); pCMV-E4orf4 (12); the
pCMV/neo vector (43); pcDNA4/TO, pcDNA6/TR
(Invitrogen); pcDNA4/TO-E4orf4 and pcDNA4/T0
expressing the R81F84A E4orf4 mutant protein (24,25);
pDAD2, pDAD2-E4orf4 (14); plasmids expressing
Acf1-GFP, Acf1-Flag, the dominant negative Acf1-
DN-GFP, SNF2h-GFP (32), SNF2h-Flag and
WSTF-Flag (44).
Speciﬁc shRNAs for Acf1, SNF2h and WSTF were
sub-cloned into pSuperior.neo-GFP (OligoEngine, Inc)
according to the manufacturer’s protocol. The following
primers were used: Acf1 shRNA forward primer: 50-GAT
CCC CGC GAT GAA GAA GAA GGT CAA ACT
CGA GTT TGA CCT TCT TCT TCA TCG CTT TTT
A-30; Acf1 shRNA reverse primer: 50-AGC TTA AAA
AGC GAT GAA GAA GAA GGT CAA ACT CGA
GTT TGA CCT TCT TCT TCA TCG CGG G-30;
SNF2h shRNA forward primer: 50-GAT CCC CCG
ACT GCT GAT GTA GTA ATT TCT CGA GAA
ATT ACT ACA TCA GCA GTC GTT TTT A-30;
SNF2h shRNA reverse primer: 50-AGC TTA AAA
ACG ACT GCT GAT GTA GTA ATT TCT CGA
GAA ATT ACT ACA TCA GCA GTC GGG G-30;
WSTF shRNA forward primer: 50-GAT CCC CGA
ACA GGA AGT TGC TGA GCT TCA AGA GAG
CTC AGC AAC TTC CTG TTC TTT TTA-30; WSTF
shRNA reverse primer: 50-AGC TTA AAA AGA ACA
GGA AGT TGC TGA GCT CTC TTG AAG CTC AGC
AAC TTC CTG TTC GGG-30.
Mutants resistant to knockdown by shRNAs were
generated from Acf1-GFP, SNF2h-Flag and WSTF-Flag
using the QuikChange mutagenesis kit (Stratagene)
according to the manufacturer’s protocols.
A catalytically inactive SNF2h mutant was prepared by
exchanging amino acid Lys211 in the nucleotide-binding
motif with Arg (K211R) using the QuikChange
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ATP hydrolysis (45,46).
Yeast strains used in this study were congenic to
W303-1A, except that a weak rad5 mutation in the
original W303 strain was repaired. The strains included
WT (W1588-4C) and itc1D, previously described (47).
Viral mutants and infections
Adenoviral mutants dl366*, lacking the complete E4
region, and dl366*+E4orf4, lacking all E4 open reading
frames (ORFs) except E4orf4, were previously
described (48). All virus infections were performed at a
multiplicity of 5 ffu (ﬂuorescent forming units) in
medium supplemented with 2% FCS at 37 C for 2h.
Immunoprecipitations and western blot analysis
For immunoprecipitation experiments, nuclear extracts
were prepared according to Dignam et al. (49). Nuclear
proteins (0.5mg) were incubated for 2h on ice with
polyclonal antibodies against Acf1, which were covalently
bound to protein A sepharose beads (Pharmacia).
Covalent antibody binding was achieved using dimethyl
pimelimidate, as described elsewhere (50). Alternatively,
the nuclear extract was incubated with an antibody
against E4orf4 or antibodies against GFP for 1h and con-
sequently with protein A sepharose beads (Pharmacia) for
an additional 1h. Finally, the samples were washed three
times with buffer C [20 mM Hepes–KOH, pH 7.9,
420mM NaCl, 1.5mM MgCl2, 0.2mM EDTA, 0.5mM
DTT, 25% v/v glycerol, 1/10 volume of complete
protease inhibitor cocktail (Roche)], boiled in SDS
loading buffer, and separated by SDS–PAGE.
Immunoprecipitated proteins and input lysates were
analyzed by western blots using speciﬁc antibodies.
To determine the levels of protein expression in the
cells, whole cell extracts were prepared in lysis buffer
[50mM Tris–HCl (pH 7.4), 250mM NaCl, 5mM
EDTA, 0.1% Triton X-100, 0.5% Nonidet P-40 and a
1/10 volume of complete protease inhibitor cocktail
(Roche)]. Proteins were analyzed by western blots using
the indicated antibodies.
Antibodies speciﬁc for the following proteins were used
in this work: E4orf4 (12), E2A-72kDa (DBP, clone B6)
(51), PP2A-B (24), PP2A-C (BD Transduction
Laboratories), GFP (MBL, Woburn, MA, USA),
SNF2h and Acf1 (Bethyl), a-Tubulin and Flag (Sigma),
HA (Covance). Polyclonal antibodies against Acf1 and
SNF2h were a kind gift of P.D. Varga-Weisz (Babraham
Institute, Cambridge, England, UK).
Cell death assays
Cells were transfected with the indicated plasmids.
Twenty-four hours post transfection, the cells were
washed with PBS, ﬁxed with 4% paraformaldehyde for
15min, washed again, incubated with 0.5% Triton
X-100 for 5min and then blocked with 5% BSA (Sigma)
for 0.5h. After staining with E4orf4 antibodies (1:500) or
with a mixture of antibodies [polyclonal anti- E4orf4
(1:1000) and monoclonal anti-Flag (Sigma), 1:1000] for
2h at 37 C, cells were washed three times for 5min each
time with PBS and incubated for 40min with
Cy3-conjugated anti-mouse antibodies [dilution 1:1000;
(Jackson)] or with a mixture of antibodies [ﬂuorescein iso-
thiocyanate (FITC)-conjugated anti-mouse antibodies
(dilution 1:200; Jackson)] and Cy3-conjugated anti-rabbit
antibodies [dilution 1:5000; (Jackson)]. The nuclei were
stained by 0.1mg/ml DAPI (Sigma). Finally, the cells
were washed three times for 5min each time with PBS
and a cover slide was mounted on the plates using
Fluoromount-G (Southern Biotechnology Associates,
Birmingham, AL, USA). Fluorescent cells were visualized
by a Zeiss Axioskop microscope at a 400-fold magniﬁca-
tion. The fraction of E4orf4-expressing cells with
condensed, abnormal or fragmented nuclei was
determined in each experiment by counting 200 trans-
fected nuclei. The average of two or three experiments,
each containing duplicate plates was calculated.
Statistical signiﬁcance of the results was determined by
a Student’s t-test.
In another assay, the cells were transfected with the
appropriate plasmids and cell monolayers were visualized
by phase microscopy and photographed, using the Zeiss
Axioskop at a 400-fold magniﬁcation.
Chromatin fractionation by salt extraction
HEK293T cells were transfected with an empty vector,
with a plasmid expressing E4orf4, or with a plasmid
expressing the R81F84A mutant. The cells were harvested
24h later, washed twice in PBS, resuspended in Chromatin
buffer A [110 mM K-acetate, 15mM Na-acetate, 2mM
Mg-acetate, 0.5mM EDTA, 0.5mM EGTA, 20mM
HEPES (pH 7.3), 0.05mg/ml digitonin and proteinase
inhibitors], and rotated for 30min at 4 C. Nuclei were
isolated by centrifugation, resuspended in chromatin
buffer B [0.5mM EGTA, 1mM HEPES (pH 7.5) and
0.5% NP40] and rocked for 10min at 4 C. The samples
were loaded on a sucrose cushion composed of 0.1M
sucrose and 0.5mM Tris–HCl (pH 8.5) and centrifuged
at 3350g for 20min. The chromatin pellet was resus-
pended in chromatin extraction buffer [0.5mM
MgCl2, 0.3M sucrose, 20mM HEPES (pH 7.5)] and was
subjected to subsequent extractions with increasing salt
concentrations (150, 250 and 500mM NaCl) in the same
buffer. Proteins were chromatographed on SDS–PAGE
and a western blot was sequentially stained with the
indicated antibodies and subjected to densitometry. The
relative band intensity for each individual extraction step
out of the sum of intensities of all extraction steps for each
protein was calculated and the ratio between control
(deﬁned as 1) and WT E4orf4 values was determined.
Image acquisition and processing
Plated cells were photographed by an Axiocam camera
linked to a Zeiss Axioskop at a 400-fold magniﬁcation.
Yeast colonies and gels were scanned with an Epson
Photo 4990 scanner. Images were processed using Adobe
PhotoShop 5.0 or 7.0.
6416 Nucleic Acids Research, 2011,Vol.39, No. 15RESULTS
E4orf4 associates speciﬁcally with Acf1 in mammalian
cells
E4orf4 participates in temporal control of adenovirus
infection and induces non-classical apoptosis in trans-
formed cells. Hypothesizing that insight into mechanisms
of E4orf4 action might be gained by the identiﬁcation of
its partner proteins, we used the Ras-recruitment system in
yeast (52) to detect new E4orf4 partners. One E4orf4 inter-
acting protein that was identiﬁed by this protocol was
Acf1, also known as Baz1A or WCRF180, that acts as
a regulatory subunit of the ACF and CHRAC
ATP-dependent chromatin-remodeling complexes
(32,53). To conﬁrm that E4orf4 associates with Acf1 in
mammalian cells, co-immunoprecipitation experiments
were carried out. A plasmid expressing E4orf4 was trans-
fected into HEK293T cells and nuclear extracts that were
prepared 24h post-transfection were immunoprecipitated
with Acf1-speciﬁc antibodies or with pre-immune serum.
Figure 1A demonstrates that E4orf4 was precipitated by
the Acf1-speciﬁc antibodies above background levels
associated with the non-speciﬁc serum. To further
conﬁrm the speciﬁcity of the E4orf4–Acf1 interaction,
a reciprocal immunoprecipitation was carried out. Cells
were transfected with plasmids expressing E4orf4 and
GFP-tagged Acf1, previously shown to retain Acf1 func-
tions (32), and E4orf4 was immunoprecipitated from
nuclear extracts. As shown in Figure 1B, Acf1-GFP was
precipitated in the presence, but not in the absence, of
E4orf4, indicating speciﬁc association between the two
proteins. Endogenous SNF2h was also present in the
E4orf4 immune complexes (Figure 1B and C), and
a similar experiment revealed that the endogenous Acf1
protein also co-precipitated with E4orf4 (Figure 1C).
When an inducible E4orf4 construct was used to
Figure 1. E4orf4 associates with Acf1 and SNF2h in mammalian cells. (A) HEK293T cells were transfected with a plasmid expressing E4orf4 or with
an empty vector. Nuclear extracts were prepared 24h later and subjected to immunoprecipitation (IP) with Acf1-speciﬁc antibodies or with
pre-immune serum. The western blot shows the presence of Acf1, the PP2A-C subunit and E4orf4 in the immune complexes and in input
lysates. The amount of proteins in the input represents 10% of the amount of proteins used for IP. (B) HEK293T cells were transfected with
a plasmid expressing Acf1-GFP, together with a plasmid expressing E4orf4 or the empty vector. Nuclear extracts were prepared as in (A) and
subjected to IP with E4orf4-speciﬁc antibodies. The western blot showing input lysates and immune complexes (IP: aE4orf4) was stained sequentially
with antibodies to E4orf4, GFP and SNF2h. The amount of proteins in the input represents 10% of the amount of proteins used for IP.
(C) HEK293T cells were transfected with a plasmid expressing E4orf4 or an empty vector and were processed as in (B). Western blots were
stained sequentially with antibodies to Acf1, SNF2h and E4orf4. (D) HEK293T cells were transfected with plasmids expressing Acf1-GFP or the
corresponding empty vector, together with a plasmid expressing E4orf4 from a doxycycline-inducible promoter and a plasmid expressing GFP, which
served as a transfection efﬁciency and loading control. Nuclear extracts were prepared at the indicated times after E4orf4 induction and subjected to
IP with GFP-speciﬁc antibodies. The western blot showing input lysates and immune complexes (IP: a-GFP) was probed sequentially with antibodies
to E4orf4 and GFP. The amount of proteins in the input represents 10% of the amount of proteins used for IP. (E) HEK293T cells were transfected
with an empty vector or a plasmid expressing Acf1-GFP and with a plasmid expressing GFP, which served as a transfection efﬁciency and loading
control. The cells were subsequently infected with dl366* or dl366*+E4orf4 adenoviruses. Cells were harvested 24h after infection and equal amounts
of nuclear extracts were subjected to IP with GFP-speciﬁc antibodies. The western blot showing input lysates and immune complexes (IP: aGFP) was
probed sequentially with antibodies to E4orf4, Acf1 and GFP.
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various times after induction of E4orf4, the interaction
with Acf1 could be detected as early as 2h post-induction
(Figure 1D), whereas apoptotic morphologies were
detected starting at 6h after induction (24). These results
suggest that the association between E4orf4 and Acf1 is an
early event in E4orf4-expressing cells that precedes induc-
tion of cell death by the viral protein. To inquire whether
E4orf4 associates with Acf1 during adenovirus infection,
HEK293T cells were transfected with an empty vector or
a plasmid expressing Acf1-GFP and with a plasmid
expressing GFP, which served as a transfection efﬁciency
and loading control. The cells were infected 24h later with
either one of two adenovirus mutants: dl366* that lacks
the complete E4 region of adenovirus or a dl366*+E4orf4
mutant devoid of all the E4 ORFs except E4orf4 (48).
We used these mutants rather than WT adenovirus to
eliminate possible complications that may be introduced
by other E4 proteins that affect chromatin response to
viral infection (54). Nuclear extracts were prepared 24h
post-infection and subjected to immunoprecipitation with
antibodies to GFP. Figure 1E demonstrates that E4orf4
and Acf1 are in complex during virus infection. It should
be noted that although it appears that Acf1-GFP (but not
native GFP) was precipitated less efﬁciently by the
GFP-speciﬁc antibodies in the presence of E4orf4
(Figures 1E and 4D), this altered efﬁciency was not
detected when endogenous Acf1 was immunoprecipitated
with Acf1-speciﬁc antibodies (Figure 1A and data not
shown), and thus may not be signiﬁcant. In sum, our
results indicate that E4orf4 and Acf1 form a speciﬁc
complex in cells both under conditions of individual
expression of E4orf4 or during virus infection.
E4orf4 targets PP2A to Acf1 and to chromatin
PP2A has been reported to be involved in all known
E4orf4 functions. We thus examined next whether PP2A
is present in the Acf1–E4orf4 protein complex. Results
presented in Figure 1A, show the presence of low but sig-
niﬁcant levels of PP2A-C in immune complexes
precipitated with Acf1-speciﬁc antibodies but not with
pre-immune serum. Moreover, PP2A-C was
co-precipitated with Acf1 in the presence of E4orf4, but
not in its absence. These results suggest that E4orf4
recruits PP2A to a complex containing Acf1. To conﬁrm
this inference, we tested whether the interaction between
E4orf4 and PP2A was required for PP2A recruitment to
Acf1. To this end we used the R81F84A E4orf4 mutant
that lacks the ability to interact with an active PP2A (25).
Results shown in Figure 2A demonstrate that the
R81F84A mutant maintained an ability to interact with
Acf1-Flag similarly to the WT E4orf4 protein. To test
whether this mutant was able to recruit PP2A to Acf1,
HEK293 cells were transfected with plasmids expressing
WT E4orf4 or the R81F84A mutant. Nuclear extracts of
transfected cells were subjected to immunoprecipitation
with Acf1-speciﬁc antibodies, and western blots were
stained with antibodies to PP2A-C, SNF2h and Acf1.
As shown in Figure 2B, PP2A-C co-precipitated with
Acf1 in the presence of WT E4orf4, but not in the
presence of the E4orf4 mutant that was incapable of inter-
acting with PP2A, whereas SNF2h co-precipitated with
Acf1 in the presence of both E4orf4 proteins. These
results are consistent with the conclusion that E4orf4
recruits PP2A to a complex with Acf1.
Since Acf1 is a component of a chromatin-associated
chromatin-remodeling protein complex, and as E4orf4
appears to recruit PP2A to the Acf1-containing complex,
we inquired whether E4orf4 increased the chromatin-
bound levels of PP2A. Since E4orf4 chromatin targets
have not been identiﬁed yet, chromatin fractionation
experiments were carried out to address this question
rather than chromatin immunoprecipitation assays.
Chromatin was extracted from nuclei of HEK293T cells
that were transfected with an E4orf4-expressing plasmid
or with an empty vector, and chromatin proteins were
successively extracted with increasing salt concentrations
and subjected to western blot analysis. Densitometer-
quantiﬁed intensities of the protein bands in blots of
control and E4orf4-expressing fractions were normalized
to the sum of the protein intensities in all fractions of the
same sample and ratios between the normalized values for
Figure 2. E4orf4 targets PP2A to an Acf1-containing complex.
(A) HEK293 cells were transfected with a plasmid expressing Acf1-
Flag together with a plasmid expressing WT E4orf4 (wt), the E4orf4
R81F84A mutant that cannot bind PP2A (mut) or the corresponding
empty vector ( ). Nuclear extracts were prepared 24h later and were
subjected to immunoprecipitation (IP) with Flag-speciﬁc antibodies or
with anti-HA antibodies, serving as control IgG. The western blot
showing input lysates and immune complexes (IP-aFlag or control
IgG) was stained sequentially with antibodies to E4orf4, SNF2h and
the Flag tag. (B) HEK293 cells were transfected with plasmids express-
ing WT E4orf4 (wt) or the E4orf4 R81F84A mutant (mut). Nuclear
extracts were prepared as in (A) and subjected to IP with Acf1-speciﬁc
antibodies or with pre-immune serum. A western blot showing input
lysates and immune complexes was stained sequentially with antibodies
to the PP2A-C subunit, SNF2h and Acf1. The amount of proteins in
the input represents 10% of the amount of proteins used for IP in both
(A) and (B).
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As seen in Figure 3A, equal amounts of Acf1, SNF2h, and
the PP2A-B55 and PP2A-C subunits were present in input
nuclear extracts from control and E4orf4-expressing cells.
The majority of Acf1, which was reported previously to
interact exclusively with SNF2h (32), was extracted from
chromatin by 250mM NaCl, and a minor amount was
extracted by 150 and 500mM salt. Most of SNF2h,
which participates in several different chromatin-
remodeling complexes, was extracted at salt concentra-
tions  250mM. However, no signiﬁcant changes were
detected in the quantities of Acf1 and SNF2h proteins
extracted at various salt concentrations from chromatin
of control or E4orf4-expressing cells. In contrast, slightly
less PP2A-B55 subunit was extracted from chromatin of
E4orf4-expressing cells at 150mM NaCl, compared with
control cell chromatin, whereas more PP2A-B55 subunit
was extracted from chromatin of E4orf4-expressing cells
at 250 and 500mM NaCl compared with control cell chro-
matin. Furthermore, the PP2A-B55 subunit was enriched
in higher salt fractions in the presence of the WT E4orf4
protein, compared with its extraction in the presence of
the R81F84A mutant incapable of binding this subunit
(Figure 3B). The PP2A-C subunit behaved similarly to
the PP2A-B55 subunit at 150 and 250mM NaCl concen-
trations, but was not enriched in chromatin proteins of
E4orf4-expressing cells extracted at 500mM NaCl
(Figure 3A). The difference between the behavior of the
B55 and C subunits of PP2A in this assay may be due to
the fact that the C subunit participates in several PP2A
heterotrimeric and heterodimeric complexes (55,56), some
of which may bind chromatin in an E4orf4-independent
manner. The results indicate that a subpopulation of
PP2A complexes containing the B55 subunit is more
tightly bound to chromatin in the presence of WT
E4orf4, allowing it to be extracted from chromatin only
at higher salt concentrations (250mM, 500mM NaCl).
The ﬁnding that WT E4orf4, but not the R81F84A
mutant, alters the chromatin binding properties of PP2A
is consistent with recruitment of PP2A to
chromatin-bound Acf1-containing protein complexes by
means of an interaction with E4orf4.
The contribution of Acf1 and SNF2h to E4orf4-induced
cell death
We next undertook to determine whether the interaction
between E4orf4 and Acf1 contributes to E4orf4-induced
cell death. It has been previously shown that the most
typical morphologies associated with E4orf4-induced cell
death include membrane blebbing, nuclear condensation
and cell detachment, whereas morphologies associated
with classical apoptosis such as DNA fragmentation,
caspase activation, phosphatidylserine externalization or
mitochondrial changes do not always accompany
E4orf4-induced cell death (9,10,15). We thus measured
E4orf4-induced cell death by assaying nuclear condensa-
tion and fragmentation, or cell loss. First, we tested
whether an Acf1-DN mutant, which is unable to bind
the SNF2h ATPase and acts in a dominant negative
fashion (32), affects E4orf4-induced cell death. HEK293
cells were transfected with an E4orf4-expressing plasmid
or with an empty vector together with plasmids expressing
GFP-tagged WT Acf1, the Acf1-DN mutant or an empty
vector. Data shown in Figure 4A demonstrate that
Acf1-DN-GFP by itself did not affect HEK293 cell
growth and E4orf4 altered cell morphology and reduced
total cell number. When Acf1-DN-GFP was co-expressed
with E4orf4, normal cell growth was partially restored.
When E4orf4-induced cell death was measured by deter-
mination of the fraction of E4orf4-expressing cells with
nuclear condensation or fragmentation, WT Acf1 was
found not to affect E4orf4-induced cell death whereas
the Acf1-DN mutant reduced cell death by 1.9-fold
(Figure 4B). Western blot analyses revealed that the
decrease in E4orf4 toxicity did not result from changes
in E4orf4 levels or unequal expression of WT and
mutant Acf1 proteins (Figure 4C), and both WT and
Acf1 mutant proteins appeared to bind E4orf4 similarly
(Figure 4D). In sum, these results suggest that E4orf4
Figure 3. A subpopulation of PP2A binds more tightly to chromatin in the presence of E4orf4. HEK293T cells were transfected with an empty
vector ( ) or a plasmid expressing E4orf4 (+) (A), or were transfected with plasmids expressing either WT E4orf4 (wt) or the R81F84A mutant (mut)
(B). Twenty-four hours later a chromatin fraction was prepared from nuclei and subjected to extraction with increasing salt concentrations. Proteins
were chromatographed on SDS–PAGE and western blots were sequentially stained with antibodies to Acf1, SNF2h, PP2A-B55, PP2A-C and E4orf4
in A or stained with antibodies to SNF2h, PP2A-B55 and E4orf4 in (B). Arrowheads mark the relevant protein bands and the asterisk marks
a non-speciﬁc band. The stained western blot was subjected to densitometry. The relative band intensity for each individual extraction step out of the
sum of intensities of all extraction steps for each sample was calculated and the ratio between control (deﬁned as 1) and E4orf4 values is shown
below the bands. The western blots shown here represent three independent experiments with similar results.
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induce cell death.
Next we determined whether SNF2h ATPase activity
was required for induction of cell death by E4orf4.
A SNF2h mutant was generated containing a K211R
mutation. The K211 residue corresponds to a lysine
residue that is essential for ATP hydrolysis and transcrip-
tional activation by Swi2 and Brg1 ATP-dependent
chromatin-remodeling factors. Substitution of this
residue by arginine was reported to produce a dominant
negative Brg1/Swi2 transcriptional activator (46).
A similar mutation was also reported to eliminate
ATPase activity of ISWI proteins in Drosophila and
Xenopus (45,57). In measuring the effects of WT SNF2h
and the SNF2h-K211R mutant on E4orf4-induced cell
death we found that whereas the WT protein did not
have any signiﬁcant effect, the mutant decreased cell
death by 1.9-fold (Figure 5A). This reduction in cell
death did not result from a decrease in E4orf4 levels, as
determined by western blot analysis (Figure 5B). Thus,
SNF2h ATPase activity appears to be required for
induction of cell death by E4orf4.
To further examine the contribution of SNF2h to
E4orf4-induced cell death we generated a HEK293-
derived cell line in which a SNF2h shRNA could be
induced by doxycycline. E4orf4-induced cell death was
measured by the appearance of nuclear aberrations
following induction of SNF2h knockdown (Figure 5C).
The results show a 2.4-fold decrease in E4orf4-induced
cell death in cells with reduced SNF2h levels relative to
the effect of E4orf4 in uninduced cells that contain normal
levels of SNF2h. Knockdown of SNF2h in control cells
did not induce cell death within the time frame of the
experiment (Figure 5C, left). These alterations in the in-
duction of cell death did not result from changes in E4orf4
levels, as determined by western blot analysis (Figure 5D).
To conﬁrm that the decrease in cell death was due to
SNF2h knockdown and not to off-target effects of the
shRNA or to effects of doxycycline treatment, E4orf4
was transfected into doxycycline-induced or uninduced
cells together with a SNF2h mutant containing silent
mutations that rendered it resistant to knockdown by
the SNF2h shRNA. Restoration of SNF2h to the
doxycycline-induced cells led to an increase in E4orf4-
Figure 4. Expression of an Acf1 mutant which cannot interact with SNF2h interferes with E4orf4-induced cell death. HEK293 cells were transfected
with plasmids expressing Acf1-GFP, Acf1-DN-GFP or GFP alone together with a plasmid expressing E4orf4 or its corresponding empty vector.
(A) A representative picture of cells containing the indicated plasmids was taken 24h after transfection, using a Zeiss Axioskop at a 400-fold
magniﬁcation. (B) Cells in duplicate plates were ﬁxed 24h after transfection and stained with E4orf4-speciﬁc antibodies and with DAPI. The number
of nuclei with abnormal morphology (condensed or fragmented) was counted in cells expressing both E4orf4 and GFP, and the percentage of cells
with abnormal nuclei was calculated. The average of two independent experiments with two replicates each is shown. Error bars represent pooled
standard deviation and statistical signiﬁcance was determined using a paired Student’s t-test. (C) Proteins were extracted from parallel plates as in (B)
and a western blot was stained sequentially with antibodies to E4orf4 and to GFP. (D) Nuclear extracts were prepared from parallel plates as in (B)
and were subjected to immunoprecipitation with antibodies to GFP. A western blot was stained sequentially with antibodies to GFP, SNF2h and
E4orf4. Input lysates represent 10% of the extracts used for the immunoprecipitation.
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death as observed in uninduced cells (Figure 5C, right).
These results are consistent with a requirement for SNF2h
in E4orf4-induced cell death.
We next conducted similar knockdown experiments to
investigate the contribution of Acf1 to E4orf4-induced cell
death. Monitoring of E4orf4-induced cell death by meas-
urement of the frequency of nuclear aberrations following
induction of Acf1 knockdown revealed a 51% increase in
cell death relative to the effect of E4orf4 in uninduced
cells that contained normal Acf1 levels (Figure 6A, left).
In contrast, knockdown of Acf1 in control cells did not
induce cell death within the time frame of the experiment
(Figure 6A, left). The results also indicate that the
observed increase in cell death was not due to a change
in the level of E4orf4 (Figure 6B). To conﬁrm that the
increase in cell death was due to Acf1 knockdown and
not to off-target effects of the shRNA or to effects of
doxycycline treatment, E4orf4 was transfected into
doxycycline-induced or uninduced cells together with a
shRNA knockdown-resistant Acf1 mutant. The uninhib-
ited activity of Acf1 in the doxycycline-induced cells di-
minished E4orf4-induced cell death to levels observed in
uninduced cells (Figure 6A, right).
Functional interaction between E4orf4 and Acf1 is
conserved in yeast cells
Since the E4orf4-PP2A-mediated cell death pathway is
conserved from yeast to mammals (14,16,18), and since
Acf1 appears to participate in this pathway, we tested
whether Itc1, the yeast Acf1 ortholog, plays a role in
E4orf4-induced toxicity in yeast. WT and itc1D yeast
cells were transformed with a plasmid expressing E4orf4
from a weak galactose-inducible promoter or with the
empty vector and were plated in serial dilutions on
glucose and galactose plates. As seen in Figure 6C, low
E4orf4 levels driven by the weak galactose-inducible
promoter caused minor inhibition of WT yeast growth,
manifested by a small reduction in colony size on
galactose relative to colonies containing only an empty
Figure 5. An active SNF2h ATPase is required for E4orf4-induced cell death. (A, B) HEK293 cells were transfected with plasmids expressing WT
SNF2h (wt), a catalytically inactive SNF2h mutant (mut) or an empty vector ( ) together with a plasmid expressing E4orf4 or its corresponding
empty vector. The SNF2h proteins were GFP tagged. Twenty-four hours later, the cells were either stained with antibodies to E4orf4 and with
DAPI or harvested for western blot analysis. Induction of cell death was measured by a DAPI assay (A), as described in the legend to Figure 4.
The average of three experiments, each containing two replicates is shown. Error bars represent pooled standard deviation and statistical signiﬁcance
was determined using a paired Student’s t-test. Proteins extracted from parallel plates were subjected to western blot analysis (B) using antibodies to
GFP and E4orf4. (C, D) Cells from a HEK293-derived cell line expressing SNF2h–shRNA from a doxycycline-inducible promoter were induced with
doxycycline (Dox) or with the solvent control (EtOH). After 3 days the cells were transfected with plasmids expressing E4orf4 or an empty vector
together with a vector control or a plasmid expressing Flag-tagged SNF2h, which was rendered resistant to the shRNA by the introduction of silent
mutations. Twenty-four hours after transfection the cells were either ﬁxed and stained with antibodies to E4orf4 and the Flag tag and with DAPI or
were extracted for western blot analysis. Induction of cell death (C) was measured by the DAPI assay described above. The average of two
experiments with two replicates each is shown. Error bars represent pooled standard deviation and statistical signiﬁcance was determined using
a paired Student’s t-test. A western blot of total lysates (D) was stained sequentially with antibodies to SNF2h, E4orf4 and a-Tubulin.
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greatly increased when E4orf4 expression was induced
from the same promoter in itc1D cells, as manifested by
the much greater reduction in colony size. These results
indicate that similarly to Acf1 deﬁciency in mammalian
cells, deﬁcit in Itc1 sensitizes yeast cells to E4orf4-
induced toxicity, demonstrating high evolutionary conser-
vation of the functional interactions between E4orf4
and Acf1.
The Acf1 homolog, WSTF, is required for E4orf4-induced
cell death
Our results indicated that knockdown of Acf1 increased
E4orf4-induced cell death but knockdown of SNF2h or
expression of a catalytically inactive SNF2h mutant
inhibited E4orf4 toxicity. These observations suggest
that E4orf4 inhibits Acf1-containing chromatin-
remodeling complexes but that it requires at the same
time other SNF2h-containing chromatin-remodeling
factors to induce cell death. WSTF is a close homolog
of Acf1, which associates with SNF2h to form WICH
chromatin-remodeling complexes that may direct SNF2h
to different chromatin targets than Acf1 (39). To examine
whether WSTF contributes to E4orf4-induced cell death,
its expression was reduced by doxycycline-induced
shRNA expression in a similar manner to the above
described knockdown of Acf1 and SNF2h. Data presented
in Figure 7 demonstrate that WSTF knockdown inhibited
E4orf4-induced toxicity. Conversely, recovery of normal
WSTF expression levels by use of a shRNA-resistant
mutant rescued the ability of E4orf4 to induce cell
death. These results suggest that a WSTF-containing
chromatin-remodeling complex is likely to contribute to
E4orf4-induced non-classical apoptosis.
Acf1 overexpression inhibits E4orf4-induced
downregulation of early viral gene expression
during adenovirus infection
Very early in adenovirus infection, the viral E1A protein
enhances cellular and early viral gene expression.
E4orf4, which accumulates during the early phase of
infection, downregulates genes that were upregulated by
E1A, thus contributing to temporal control of the
progression of virus infection (4). We next inquired
whether the interaction of Acf1 with E4orf4 contributes
to the downregulation of early viral gene expression.
HEK293 cells were transfected with a plasmid expressing
Acf1-GFP or with an empty vector and were subsequently
infected with dl366* or dl366*+E4orf4 viruses. The
cells were harvested 24h post-infection and cell extracts
were subjected to western blot analysis. Results shown
in Figure 8 as well as a previous report (3), indicate
that expression of the early adenovirus E2A-72kDa
protein was reduced when cells were infected with
the dl366*+E4orf4 virus as compared to its expression
in cells infected with dl366* that lacks E4orf4. However,
in cells that overexpress Acf1 the E4orf4-induced
reduction in E2A-72kDa protein expression was
inhibited. These results suggest that to achieve inhibition
Figure 6. Acf1 knockdown enhances E4orf4-induced toxicity. (A, B)
Cells from a HEK293-derived cell line expressing Acf1-shRNA from
a doxycycline-inducible promoter were induced with doxycycline (Dox)
or with the solvent control (EtOH). After 3 days the cells were
transfected with plasmids expressing E4orf4 or an empty vector
together with a plasmid expressing GFP-tagged Acf1, which was
rendered resistant to the shRNA by the introduction of silent mutations
or its corresponding empty vector. Twenty-four hours after transfection
the cells were either ﬁxed and stained with antibodies to E4orf4 and
with DAPI, or were extracted for western blot analysis. Induction of
cell death (A) was measured by the DAPI assay described above.
The average of two experiments with two replicates each is shown.
Error bars represent pooled standard deviation and statistical signiﬁ-
cance was determined using a paired Student’s t-test. A western blot of
total lysates (B) was stained sequentially with antibodies to Acf1,
E4orf4 and a-Tubulin. (C) WT300 and itc1D yeast cells were trans-
formed with the plasmid pDAD2-E4orf4, expressing E4orf4 from
a weak galactose-inducible promoter or with the empty vector. The
yeast cells were serially diluted (1:5) and plated on glucose and
galactose plates.
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inhibit Acf1.
DISCUSSION
E4orf4-induced cell death is a unique mode of
non-classical programmed cell death and the mechanisms
underlying this process are poorly understood. E4orf4 as-
sociates with two major partners, PP2A (2) and Src
kinases (22), which contribute additively to its cell
death-inducing activities (21). The association of E4orf4
with Src has been reported to lead to ‘cytoplasmic cell
death’ (58) by perturbing cytoskeletal tension and
endosomal trafﬁc through a Src-Cdc42-Rab11a-
dependent pathway (59). The present report shows,
however, that the interaction of E4orf4 with PP2A is
linked to its association with a chromatin-remodeling
complex and with chromatin (Figures 1–3), enabling
E4orf4 to exert its effect in the nucleus. The interaction
between E4orf4 and Acf1 was observed as early as 2h
post-induction of E4orf4 expression (Figure 1D), suggest-
ing that it is one of the earliest events induced by the viral
protein. Previous reports showed that E4orf4 localizes to
nuclei early after induction of its expression, and accumu-
lates in the cytoplasm and membranes at a later stage,
in correlation with its phosphorylation by Src kinases
(24,60).
The E4orf4–PP2A–Acf1 interaction
Our results demonstrate that E4orf4 recruits PP2A to a
complex with Acf1 and to chromatin (Figures 1–3). The
low interaction levels between PP2A and Acf1 in the
presence of E4orf4 might be due to their transient inter-
action or to the high salt concentration in the extraction
buffer, which may have partially destabilized the complex.
However, PP2A was detected above background levels in
the Acf1 complexes, indicating a signiﬁcant level of inter-
action between the two proteins. Although it has been
previously proposed that E4orf4 induces cell death by in-
hibiting PP2A activity (61), results presented in that report
were also consistent with inhibition of a PP2A-like phos-
phatase such as PP6. It has indeed been demonstrated that
inhibition of PP6 contributes to E4orf4-induced cell death
(62). Furthermore, it is not clear yet how E4orf4 affects
PP2A activity towards the still unidentiﬁed physiological
substrates of the E4orf4–PP2A complex. The novel
ﬁnding presented here that E4orf4 targets PP2A to Acf1
and to chromatin suggests that, rather than to be in-
hibited, PP2A is recruited to dephosphorylate chromatin
Figure 7. WSTF knockdown inhibits E4orf4-induced cell death. (A, B)
Cells from a HEK293-derived cell line expressing WSTF-shRNA from
a doxycycline-inducible promoter were induced with doxycycline (Dox)
or with the solvent control (EtOH). After 3 days the cells were trans-
fected with plasmids expressing E4orf4 or an empty vector together
with a plasmid expressing Flag-tagged WSTF, which was rendered
resistant to the shRNA by the introduction of silent mutations, or its
corresponding empty vector. Twenty-four hours after transfection the
cells were either ﬁxed and stained with antibodies to the Flag tag and
E4orf4 and with DAPI, or were extracted for western blot analysis.
Induction of cell death (A) was measured by the DAPI assay described
above. The average of two independent experiments with two replicates
each is shown. Error bars represent pooled standard deviation and
statistical signiﬁcance was determined using a Student’s t-test. A
western blot of total lysates (B) was stained sequentially with antibodies
to WSTF, E4orf4 and a-Tubulin.
Figure 8. Acf1 overexpression inhibits downregulation of the early
adenovirus E2A-72kDa protein by E4orf4. HEK293 cells were trans-
fected with plasmids expressing Acf1-GFP or GFP alone and were
subsequently either mock-infected (M) or infected with the adenovirus
mutants dl366* or dl366*+E4orf4. The cells were harvested 24h
post-infection and protein extracts were prepared and chromatographed
on SDS–PAGE. A western blot was stained sequentially with
antibodies to GFP, E2A-72kDa, a-Tubulin and E4orf4. This blot
represents three independent experiments with similar results.
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the E4orf4–PP2A complex may then lead to alterations in
local chromatin structure, resulting in altered transcrip-
tion, DNA replication, or other processes requiring
chromatin-remodeling. Examples showing that the phos-
phorylation status of subunits of ATP-dependent
chromatin-remodeling factors can affect their function
have been previously described. WSTF, an Acf1
homolog, is phosphorylated in response to MAPK activa-
tion, and as a result is targeted to the Swi/Snf-containing
WINAC chromatin-remodeling complex rather than to
the SNF2h-containing WICH complex (63). The Swi/Snf
ATPases Brm and Brg-1 are phosphorylated in mitosis,
and thus are excluded from the chromosomes (64).
However, at this point we cannot rule out an alternative
possibility by which the recruitment of PP2A to chromatin
provides a non-catalytic function, analogous to its
function in the chromosomal association of condensin II
(65). These possibilities are currently under investigation.
Functional interactions between E4orf4 and the ACF
chromatin-remodeling factor
In addition to their physical association with E4orf4, we
show here that both Acf1 and SNF2h subunits of the ACF
chromatin-remodeling factor interact functionally with
the viral protein. A catalytically inactive SNF2h protein
and SNF2h knockdown were shown to inhibit E4orf4-
induced cell death (Figure 5), whereas Acf1 knockdown
enhanced it (Figure 6). The functional interaction between
E4orf4 and Acf1 is highly conserved in evolution as
demonstrated by the enhanced toxicity of E4orf4 in
yeast following deletion of the yeast Acf1 ortholog
Itc1 (Figure 6C). The data indicate that SNF2h activity
is required for E4orf4-induced cell death whereas Acf1 or
Acf1-containing complexes must be inhibited. Based on
these results we offer a model, schematically portrayed
in Figure 9, of the mode of action of E4orf4. This model
posits that E4orf4 inhibits an Acf1-containing complex by
targeting PP2A to it, which consequently results in
enhancement of the activity of other SNF2h-containing
complexes. The shift in chromatin-remodeling activity
induced by E4orf4 could lead to changes in transcription
or DNA replication, which might result in cell death.
This model is supported by the ﬁnding that knockdown
of WSTF, an Acf1 homolog that is also found in
SNF2h-containing complexes, leads to inhibition of
E4orf4-induced cell death (Figure 7). According to the
model, WSTF knockdown prevents replacement of the
inhibited Acf1–SNF2h complexes by WSTF–SNF2h
complexes, and therefore obstructs induction of cell
death. It should be noted that we could not detect
a physical interaction between E4orf4 and WSTF.
However, such an interaction is not required by the
suggested model. The Acf1 mutant, which is unable to
bind SNF2h, was found to inhibit E4orf4-induced cell
death (Figure 4). This ﬁnding is also consistent with the
model proposed here since this mutant can be targeted to
chromatin even without binding SNF2h (32) and could
thus block the accessibility of other SNF2h-containing
complexes to the relevant chromatin sites, preventing
them from inducing cell death.
How does recruitment of PP2A to ACF by E4orf4
inhibit this complex? It is possible that PP2A activity
causes the ACF complex to dissociate thus facilitating
SNF2h association with other regulatory subunits. We
could not detect a signiﬁcant decrease in Acf1 binding to
SNF2h in co-immunoprecipitation experiments, nor
changes in co-localization of Acf1 and SNF2h in cells by
confocal microscopy (results not shown). We also found
both SNF2h and Acf1 in E4orf4-containing complexes
(Figure 1). Although these observations exclude the pos-
sibility of global dissociation, they are not inconsistent
with local dissociation events that are restricted to and
affect speciﬁc chromosomal sites. Alternatively, the ACF
complex could be released from chromatin, to be replaced
by other SNF2h-containing complexes. Here too, we did
not observe global changes in chromatin association of
Acf1 or SNF2h (Figure 3). A third possibility is that
Figure 9. A working model: E4orf4 functions by shifting the balance between different SNF2h-containing chromatin-remodeling complexes. Various
SNF2h-containing complexes participate in chromatin remodeling and affect transcription, DNA replication, DNA repair, etc. E4orf4 targets PP2A
to Acf1-containing chromatin remodelers and inhibits them. This inhibition leads to a shift in the balance between various SNF2h remodeling
complexes, allowing, for example, more activity of a WSTF–SNF2h complex. The variation in chromatin remodeler activity alters chromatin
remodeling and produces changes in transcription, DNA replication, DNA repair or other processes that require remodeling. These events contribute
to E4orf4 functions during virus infection and lead to cell death when E4orf4 is expressed individually.
6424 Nucleic Acids Research, 2011,Vol.39, No. 15E4orf4-PP2A inhibits ACF remodeling activity. These
possibilities will have to be addressed in future studies.
Chromatin remodeling and cell death
It is not currently known how the physical and functional
interactions between E4orf4 and the ACF chromatin-
remodeling complex as well as the functional interactions
with WSTF contribute to E4orf4-induced cell death.
These interactions may affect DNA-dependent processes,
including transcription, replication or repair. WSTF has
been shown to be involved in regulation of the DNA
damage response by phosphorylating H2A.X on Tyr142
(41). This novel histone modiﬁcation appears to determine
the relative recruitment of either DNA repair or
pro-apoptotic factors to sites of DNA damage, and
thus, the balance between phosphorylation and
dephosphorylation of H2A.X Tyr142 may constitute a
switch mechanism that modulates survival/apoptotic
decisions (66). Based on our results, a switch regulating
survival versus cell death may also be achieved by an
E4orf4–PP2A-induced shift in the balance between
Acf1-SNF2h and WSTF-SNF2h in chromatin. ACF was
shown to be required for the regulation of both transcrip-
tion and DNA replication (32,37), and Acf1 and Snf2h
have recently been shown to contribute to double-strand
break repair as well (38). Modulation of any of these
processes may entail a situation that is not compatible
with cell survival. In any event, our current study
establishes a novel function for the Acf1 chromatin-
remodeling factor in life and death decisions.
Chromatin remodeling during adenovirus infection
We have shown here that E4orf4 binds Acf1 within the
context of adenovirus infection (Figure 1E), suggesting
that their interaction contributes to the viral life cycle.
E4orf4 is a downregulator of both cellular and early
adenoviral gene expression, and the interaction with
PP2A is required for this activity (1–4,24). Acf1 was also
shown to contribute to downregulation of the expression
of speciﬁc genes, including wingless-regulated and vitamin
D3 receptor-regulated genes (34,35). In this report, we
showed that Acf1 overexpression inhibited E4orf4-
induced downregulation of one of the early adenovirus
proteins, the E2A-72kDa protein, whereas Acf1 over-
expression in the absence of E4orf4 did not affect E2A-
72kDa expression (Figure 8). These results suggest that
activation and downregulation of E2A-72kDa expression
are carried out by distinct mechanisms. Whereas activa-
tion of E2A expression has been described and is achieved
by E1A-induced displacement of Rb proteins from the
E2F transcription factor and subsequent E2F dimeriza-
tion facilitated by the adenovirus E4orf6/7 protein
[reviewed in (67)], it remains to be seen whether downregu-
lation of expression of this early viral protein results from
a direct or an indirect effect of Acf1. However, the ﬁnding
that Acf1 counteracts E4orf4 activity during virus infec-
tion is consistent with the ﬁnding that Acf1 knockdown
enhances E4orf4-induced cell death, and both results
indicate that the activities of E4orf4 and Acf1 counteract
each other.
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